Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea

NCT ID: NCT02951364

Last Updated: 2021-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1081 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-12-05

Study Completion Date

2021-06-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this post-marketing surveillance study is to collect and assess data related to the safety and effectiveness of Harvoni® (ledipasvir/sofosbuvir (LDV/SOF)) treatment regimen, per the approved Korea prescribing information for Harvoni, in routine clinical practice in Korea and to report the results to the Ministry of Food and Drug Safety (MFDS). Participants will be treated as part of routine practice at Korean healthcare centers by accredited physicians.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatitis C Virus

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

observational

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LDV/SOF

Adult Korean participants and pediatric Korean participants aged 12 to \<18 years with genotype 1, 2, 4, 5, and 6 chronic HCV infection who are initiating commercial Harvoni regimen

LDV/SOF

Intervention Type DRUG

90/400 mg tablet administered orally once daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LDV/SOF

90/400 mg tablet administered orally once daily

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Harvoni® GS-5885/GS-7977

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals aged 12 years and older who are living in Korea
* Adult individuals who have been informed of all pertinent aspects of the study and have voluntarily signed a Personal Information Protection Act (PIPA) consent form; Pediatric individuals who have the individuals' legally authorized representatives sign the PIPA consent form

Exclusion Criteria

* Individuals treated with Harvoni outside of the approved prescribing information in Korea
* Individuals who have a contra-indication to Harvoni
* Individuals who have a contra-indication to ribavirin
* Pregnant or breastfeeding women
* Individuals who have previously been administered Harvoni
* Individuals participating in a concurrent HCV clinical trial
* Individuals planning on leaving the country during the study period
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gilead Sciences

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gilead Study Director

Role: STUDY_DIRECTOR

Gilead Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHA Bundang Medical Center

Seongnam-si, Gyeonggido, South Korea

Site Status

Hallym University Sacred Heart Hospital

Anyang-si, , South Korea

Site Status

SoonChunHyang University Bucheon Hospital

Bucheon-si, , South Korea

Site Status

The Catholic University of Korea Bucheon ST. Mary's Hospital

Bucheon-si, , South Korea

Site Status

Bumin Hospital Haeundae

Busan, , South Korea

Site Status

Inje University Haeundae Paik Hospital

Busan, , South Korea

Site Status

Good Gang-An Hospital

Busan, , South Korea

Site Status

Dong-A University Medical Center

Busan, , South Korea

Site Status

Pusan National University Hospital

Busan, , South Korea

Site Status

Kosin University Gospel Hospital

Busan, , South Korea

Site Status

Inje University Busan Paik Hospital

Busan, , South Korea

Site Status

Busan St. Mary's Hospital

Busan, , South Korea

Site Status

Busan Veterans Hospital

Busan, , South Korea

Site Status

Maryknoll Medical Center

Busan, , South Korea

Site Status

Changwon Fatima Hospital

Changwon, , South Korea

Site Status

Dankook University Hospital

Cheonan, , South Korea

Site Status

SoonChunHyang University Cheonan Hospital

Cheonan, , South Korea

Site Status

Hallym University ChunCheon Sacred Heart Hospital

Chuncheon, , South Korea

Site Status

Konkuk University Chungju Hospital

Chungju, , South Korea

Site Status

Keimyung University Dongsan Medical Center

Daegu, , South Korea

Site Status

Yeungnam University Medical Center

Daegu, , South Korea

Site Status

Daegu Catholic University Medical Center

Daegu, , South Korea

Site Status

Kyungpook National University Hospital

Daegu, , South Korea

Site Status

Kyungpook national university medical center Chil-Gok

Daegu, , South Korea

Site Status

Chungnam National University Hospital

Daejeon, , South Korea

Site Status

Konyang University Hospital

Daejeon, , South Korea

Site Status

GangNeung Asan Hospital

Gangneung-si, , South Korea

Site Status

Dongguk University Ilsan Hospital

Goyang, , South Korea

Site Status

Myongji Hospital

Goyang, , South Korea

Site Status

National Health Insurance Corporation Ilsan Hospital

Goyang-si, , South Korea

Site Status

Kumi Cha Hospital

Gumi, , South Korea

Site Status

Chosun University Hospital

Gwangju, , South Korea

Site Status

Kwangju Christian Hospital

Gwangju, , South Korea

Site Status

Hanyang University Guri Hospital

Gyeonggi-do, , South Korea

Site Status

Dongguk University Gyeongju Hospital

Gyeongju, , South Korea

Site Status

Hallym University Dongtan Sacred Heart Hospital

Hwaseong-si, , South Korea

Site Status

Chonnam National University Hwasun Hospital

Hwasun, , South Korea

Site Status

WonKwang University Hospital

Iksan, , South Korea

Site Status

The Catholic University of Korea, Incheon St. Mary's Hospital

Incheon, , South Korea

Site Status

Inha University Hospital

Incheon, , South Korea

Site Status

Gachon University Gil Medical Center

Incheon, , South Korea

Site Status

Cheju Halla General Hospital

Jeju City, , South Korea

Site Status

Presbyterian Medical Center

Jeonju, , South Korea

Site Status

Chonbuk National University Hospital

Jeonju, , South Korea

Site Status

Gyeongsang National University Hospital

Jinju, , South Korea

Site Status

Seoul National University Bundang Hospital

Seongnam-si, , South Korea

Site Status

Korea University Anam Hospital

Seoul, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Kangbuk Samsung Hospital

Seoul, , South Korea

Site Status

Severance Hospital

Seoul, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

SoonChunHyang University Hospital

Seoul, , South Korea

Site Status

Hanyang University Hospital

Seoul, , South Korea

Site Status

Konkuk University Medical Center

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Kangdong Sacred Heart Hospital

Seoul, , South Korea

Site Status

Gangnam Severance Hospital

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Chung-Ang University Hospital

Seoul, , South Korea

Site Status

SMG - SNU Boramae Medical Center

Seoul, , South Korea

Site Status

Ewha Womans University Mokdong Hospital

Seoul, , South Korea

Site Status

Inje University Seoul Paik Hospital

Seoul, , South Korea

Site Status

Korea University Guro Hospital

Seoul, , South Korea

Site Status

Eulji General Hospital

Seoul, , South Korea

Site Status

Inje University Sanggye Paik Hospital

Seoul, , South Korea

Site Status

The Catholic University of Korea, St. Vincent's Hospital

Suwon, , South Korea

Site Status

The Catholic University of Korea Uijeongbu St. Mary's Hospital

Uijeongbu-si, , South Korea

Site Status

Ulsan University Hospital

Ulsan, , South Korea

Site Status

DongKang Hospital

Ulsan, , South Korea

Site Status

Ulsan Hospital

Ulsan, , South Korea

Site Status

Yonsei University Wonju Severance Christian Hospital

Wŏnju, , South Korea

Site Status

Pusan National University Yangsan Hospital

Yangsan, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GS-US-337-1966

Identifier Type: -

Identifier Source: org_study_id